Skip to content

Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo

A Pilot Feasibility Trial of Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05122663
Acronym
ED-VeRT
Enrollment
125
Registered
2021-11-17
Start date
2021-11-16
Completion date
2023-05-01
Last updated
2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dizziness, Vertigo

Brief summary

ED-VeRT will enroll up to 125 adult emergency department (ED) patients presenting with a chief complaint of dizziness or vertigo to collect longitudinal outcomes over 3 months of follow-up. This will include 50 patients who were evaluated by an ED physical therapist (ie, vestibular rehabilitation) during their ED visit and 50 patients who received usual care. The aims of this trial are to: (1) obtain initial estimates of participant recruitment and retention, intra-cluster correlation, and between-group outcome differences that will inform sample size calculation for a future randomized clinical trial, and (2) assess feasibility and fidelity of a clinical classification protocol for undifferentiated dizziness among patients receiving ED vestibular rehabilitation.

Interventions

BEHAVIORALVestibular Rehabilitation

Vestibular Rehabilitation refers to the specific interventions that physical therapists provide to patients with dizziness and vertigo symptoms. These interventions can involve repositioning maneuvers, habituation exercises, gaze stabilization, and/or balance training exercises, depending on the specific etiology of dizziness and vertigo per an established clinical protocol utilizing a patient's history and exam findings. Physical therapists instruct patients in how to perform these exercises at home and provide instructions and referral for patients to follow-up with an outpatient physical therapist for further care.

OTHERUsual Care

Usual Care refers to any combination of diagnostic testing, medications, and patient education or counseling provided by a patient's treating ED physician.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chief complaint relating to dizziness or vertigo * Ability to complete follow-up data collection electronically or by telephone * English-speaking

Exclusion criteria

* Severe neurologic deficit concerning for ischemic or hemorrhagic stroke * Known pregnancy, under police custody, unable to consent

Design outcomes

Primary

MeasureTime frameDescription
Dizziness Handicap Inventory (DHI)Three months after the index ED visit.The DHI contains 25 items quantifying self-perceived handicapping effects of dizziness symptoms.

Secondary

MeasureTime frameDescription
Vestibular Activities Avoidance Instrument (VAAI-9)Three months after the index ED visit.The VAAI-9 identifies fear avoidance beliefs in persons with dizziness. The VAAI-9 is the 9-item short form version of the VAAI.
ED Diagnostic Imaging UtilizationIndex ED visit (one day)The proportion of ED visits in which any diagnostic imaging of the brain was performed, including computed tomography and magnetic resonance imaging.
ED Length of StayIndex ED visit (up to one week)Total length of stay, inclusive of hospitalizations and observation stays.
Patient-Reported Medication Use in Last 24 HoursThree months after the index ED visit.Patient-reported medication use for dizziness will be collected using a standardized instrument assess whether participants have taken any dizziness medication in the last 24 hours (binary yes/no). The 24-hour timeframe was selected to maximize accuracy in patient recall. In brief, dizziness medications are listed by brand and generic names; a yes response to any medication triggers an additional query asking the participant to specify the medication dose (e.g., meclizine 25mg) and quantity (e.g., one pill).

Other

MeasureTime frameDescription
Global Rating of Change (GROC)Three months after the index ED visit.The GROC is a single-item survey used to evaluate overall recovery from the time that symptoms began until now. Responses are provided on a 15-point Likert scale ranging from a very great deal worse to a very great deal better.
Numeric Rating Scale (NRS)Three months after the index ED visit.The NRS measures intensity of dizziness symptoms from 0 to 10. Participants will report average dizziness intensity over the last 24 hours.
Advanced Healthcare UtilizationThree months after the index ED visit.Proportion of participants who utilized any advanced healthcare resources for dizziness after their index ED visit, defined as advanced imaging (e.g., computed tomography, magnetic resonance imaging) or procedures/surgery.
Benzodiazepine Prescription FillingThree months after the index ED visitBenzodiazepine prescription filling data will be queried in the state prescription monitoring database.
Follow-up with Outpatient Physical TherapyThree months after the index ED visitProportion of participants who reports outpatient physical therapy follow-up for vestibular rehabilitation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026